{
    "@graph": [
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A1653861320",
            "@type": "bibo:Book",
            "P1053": "Online-Ressource (302 p)",
            "contributor": "Mart\u00ednez, Ana",
            "description": "Campusweiter Zugriff (Universit\u00e4t Hannover).- Vervielf\u00e4ltigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots.",
            "identifier": [
                "(isbn13)9781849731072",
                "(isbn)1849731071",
                "(ppn)1653861320",
                "(doi)10.1039/9781849731072",
                "(isbn13)9781849730648",
                "(firstid)BSZ:491717113"
            ],
            "publisher": "Royal Society of Chemistry",
            "subject": [
                "(classificationName=linseach:mapping)rest",
                "Neuroplasticity",
                "(classificationName=ddc)616.831061",
                "Alzheimer's disease",
                "Alzheimer's disease; Chemotherapy",
                "(classificationName=loc)RC523 .E63 2010",
                "Electronic books",
                "(classificationName=loc)RC523",
                "Drug targeting"
            ],
            "title": "Emerging drugs and targets for Alzheimer's disease : Volume 2: Neuronal plasticity, neuronal protection and other miscellaneous strategies",
            "abstract": [
                "Alzheimer's disease is the most prevalent type of neurodegenerative disorder in the elderly. A recent study from Bloomberg School of Public Health estimated that more than 26 million people worldwide were living with the disease in 2006 and that the global prevalence of the disease will grow to more than 106 million by 2050. By that time, 43 per cent of those living with the disease will need high-level care, equivalent to that of a nursing home. However, even if modest advances in preventing or delaying the disease's progression were made, it could have a huge impact on global public health",
                "Neuronal Plasticity as target -- Chapter 15: Regeneration of Degenerated Brain: A Promising Therapeutic Target -- Chapter 16: Promoting synaptic resilience in AD patients through PDE inhibition -- Chapter 17: A new generation of non invasive NGF-based therapies for Alzheimer's disease -- Chapter 18: Possible clinical applications of stem cell strategies in AD therapies -- Neuronal protection as target -- Chapter 19: Targeting Oxidative Mechanisms in Alzheimer Disease -- Chapter 20: Davunetide (NAP) Pharmacology: Neuroprotection and tau -- Chapter 21: Targeting NF- B inflammatory and pro-survival signaling in AD -- Chapter 22: PPAR in Alzheimer's disease -- Miscellaneous targets and strategies -- Chapter 23: Serotonin 5-HT4 receptors as pharmacological targets for the treatment of Alzheimer's disease -- Chapter 24: Liver X Receptors as potential therapeutic target for AD -- Chapter 25: Discovery of memoquin, a multi-target-directed ligand for the treatment of Alzheimer's disease -- Chapter 26: RNA interference of genes related to AD -- Chapter 27: Medicinal plants, phytochemicals and Alzheimer's Disease"
            ],
            "dcterms:contributor": "Technische Informationsbibliothek (TIB)",
            "isPartOf": "(collectioncode)ZDB-1-RSEK",
            "issued": "2010",
            "language": "http://id.loc.gov/vocabulary/iso639-1/en",
            "license": "commercial licence",
            "medium": "rda:termList/RDACarrierType/1018",
            "tableOfContents": "http://www.gbv.de/dms/bowker/toc/9781849731072.pdf",
            "isLike": "doi:10.1039/9781849731072",
            "P30128": "RSC drug discovery",
            "P60163": "Cambridge"
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "P30128": "http://www.rdaregistry.info/Elements/m/#P30128",
        "contributor": "http://purl.org/dc/elements/1.1/contributor",
        "P60163": "http://www.rdaregistry.info/Elements/u/#P60163",
        "issued": "http://purl.org/dc/terms/issued",
        "description": "http://purl.org/dc/elements/1.1/description",
        "title": "http://purl.org/dc/elements/1.1/title",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "abstract": "http://purl.org/dc/terms/abstract",
        "license": "http://purl.org/dc/terms/license",
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "tableOfContents": "http://purl.org/dc/terms/tableOfContents",
        "publisher": "http://purl.org/dc/elements/1.1/publisher",
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "isLike": {
            "@id": "http://umbel.org/umbel#isLike",
            "@type": "@id"
        },
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}